YUVEZZITM: the first and only combination eye drop approved to treat presbyopia.
Tenpoint Therapeutics secured $235M through a Series B Financing and Credit Facility.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Advertisement
